cyclophosphamide/doxorubicin/prednisone/teniposide protocol

Known as: CICS, CHVP, CHVP protocol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PURPOSE Cancer-initiating cells (CIC) are considered to represent the subpopulation of tumor cells that is resistant to… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The FL2000 study was undertaken to evaluate the combination of the anti-CD20 monoclonal antibody rituximab with chemotherapy plus… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE High amounts of intratumoral macrophages have been shown to correlate with poor prognosis in patients with follicular… (More)
Is this relevant?
2007
2007
Ciclesonide (CIC) is an inhaled glucocorticosteroid. This study aimed to identify esterases involved in the metabolism of CIC to… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The purpose of this study is to compare our standard chemotherapy regimen (CHVP [cyclophosphamide, doxorubicin, teniposide, and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE We prospectively evaluated the efficacy and durability of botulinum-A toxin in the treatment of detrusor hyperreflexia in… (More)
Is this relevant?
1999
1999
Sili con detectors produced from materials with different doping and oxygen concentration have been irradiated with 27 MeV and 23… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • table 3
Is this relevant?
1998
1998
This chapter describes recent advances in genetic programming of machine code. Evolutionary program induction of binary machine… (More)
  • figure 6.1
  • figure 6.2
  • figure 6.3
  • figure 6.4
  • figure 6.5
Is this relevant?
1983
1983
Although it is generally considered that vasculitis of the polyarteritis nodosa (PAN) group and Wegener's granulomatosis (WG) is… (More)
Is this relevant?